In the palliative situation, i.e., when the tumour could not be removed and remains in the patient, when metastases have formed and other organs are affected, we have a response rate of 60 to 65 percent with dendritic cell therapy alone, depending on the form of cancer according to WHO criteria.
This can be increased with viral therapy.
In the laboratory, the patient’s dendritic cells are combined with the cancer antigen and a special virus that can only attack cancer cells.
This helps the immune system to better recognise the enemy, the cancer cell.
Before starting therapy, the medical records are reviewed by the doctors at the clinic. This can take place during an initial consultation at the clinic or via teleconference with the patient. A blood test is required to check the immune system and tumour activity. This can be done at the clinic or at the patient’s home in an appropriately trained laboratory.
This is followed by the development of the therapy strategy – until this is ready it takes about 2 weeks.
Duration: 8 days
This starts with the blood collection – see treatment procedure dendritic cells-.
Unlike dendritic cell therapy where patients go home between blood collection and injection of activated cells, patients stay at the clinic. For 8 days. During this time, the virus is administered, combined with hyperthermia applications, vitamins and trace elements.
Duration 8 days
This is a second cycle with the dendritic cells, the virus administration and hyperthermia plus vitamins and trace elements.
After 3 weeks the success of the vaccination is examined
Costs can be different for each patient, as the therapy offer is tailored to each individual patient.
As a guideline:
Cost of laboratory tests:
The total cost for 2 therapy sessions is at least EUR 60’000